The 17-page FDA inspection report conducted in late April detailed quality and security lapses at the Fort Washington, PA-based facility, which is owned by Johnson & Johnson’s McNeil PPC drug manufacturing division. The agency said it is considering a wide range of actions including possible criminal penalties. Read full story here